Vera Clinic FUE Hair Transplant and Hair Restoration

Vera Clinic at a Glance

Credibility and Accreditation

• Practitioner types: Plastic surgeons and dermatologists (named practitioners 
• Ethics approval: Study protocols reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Xi'an Medical University
• Regulatory compliance: Adheres to European Rules and Italian 'Law-Decree of the Blood' governing non-transfusional blood component safety (applicable to PRP protocols)
• Referenced professional standards: International Society of Hair Restoration Surgery (ISHRS); International Society of Aesthetic Plastic Surgery (ISAPS)
• Published research: Clinical outcomes published in BMC Surgery and the International Journal of Molecular Sciences
• Patient satisfaction: 98%+ in retrospective clinical studies; TrustScore 4.8/5 from over 1,800 verified reviews, with 95% of reviewers awarding five stars

Clinic Overview

Vera Clinic operates as a hospital-based Medical Cosmetology Department, positioning its hair restoration work within a clinical rather than a spa environment. Its primary specialisation is androgenetic alopecia the most prevalent form of progressive hair loss in both men and women addressed through a range of surgical, regenerative, and pharmacological interventions.

The clinic's clinical approach is oriented around published evidence. Outcome data from its FUE programme appear in peer-reviewed literature, including a retrospective study of 158 male patients that documented a follicle survival rate exceeding 90% and a patient satisfaction rate above 98%. The clinic references ISHRS and ISAPS standards in its protocols and operates under ethics committee oversight for clinical study activities.

The patient population spans first-time candidates exploring surgical restoration, individuals who have not responded adequately to pharmacological treatments, and patients seeking regenerative options as either a standalone approach or an adjunct to surgery.

Treatments and Services

Vera Clinic offers treatment across four broad categories: surgical hair restoration, regenerative therapies, pharmacological management, and non-invasive or minimally invasive adjunct treatments.

Surgical: 

Follicular Unit Extraction (FUE) and Follicular Unit Transplantation (FUT) address permanent hair loss by relocating genetically stable follicles to areas of thinning or baldness. FUE is the primary surgical method; FUT is reserved for patients requiring a high follicular yield in a single session where linear scarring is acceptable.

Regenerative: 

Platelet-Rich Plasma (PRP) therapy uses autologous blood components to deliver concentrated growth factors to the scalp. Adult stem cell-based therapy (ASCs-BT) and adipose-derived stem cell conditioned medium infusion target follicle regeneration through cell-signalling mechanisms. These approaches are used both independently and as surgical adjuncts.

Pharmacological: 

Topical Minoxidil (2% or 5%) and oral Finasteride (1 mg/day) are offered as first-line or complementary treatments. Both are established in clinical evidence and require ongoing use to maintain benefit.

Adjunct and non-invasive: 

Low-Level Laser Therapy (LLLT) and micro-needling often combined with topical agents complete the treatment range. These are typically integrated into a wider protocol rather than used in isolation.

Core Treatments in Detail

Follicular Unit Extraction (FUE)

• Category: Surgical
• Technique: Individual follicular units extracted using a LeadM-FUEPK-7000 motorised device with 0.8–1 mm sharp punches; implanted using 1.0–1.2 mm gem knives. Anaesthesia via ring nerve block, local Lidocaine infiltration, and tumescent solution with Epinephrine.
• Treatment Time: Single session 
• Best Suited For: Males with Hamilton-Norwood grades II–V; females with Ludwig stage I–III; patients who have not responded to pharmacological treatment; patients seeking permanent restoration without a linear scar
• Recovery: Oedema resolves within 2–3 days; sterile cap removed at day 3; hair washing begins at day 6; initial recovery period 6–20 days; full assessment at 12–24 months
• Results Duration: Transplanted follicles from non-balding donor areas are designed to produce terminal hair growth permanently
• Key Notes: Retrospective data from 158 male patients documented a follicle survival rate exceeding 90%, with 85% of patients achieving survival rates above 95%. Average surviving hair density was 35.2 ± 4.3 roots/cm². Complication rate was below 6%. Not indicated for Hamilton-Norwood grade I or grade VI and above.

Follicular Unit Transplantation (FUT)

• Category: Surgical
• Technique: Removal of a scalp strip from the donor area, dissected into individual follicular units for implantation
• Best Suited For: Patients with extensive hair loss requiring a high follicular yield in a single session; suitable where linear scarring at the donor site is acceptable
• Recovery: Longer than FUE owing to greater tissue trauma; linear scar at donor site
• Results Duration: Designed for permanent outcomes from non-balding donor follicles
• Key Notes: FUT is generally reserved for cases where FUE cannot deliver sufficient graft numbers in one procedure. The trade-off is a linear scar versus the punctate scarring pattern of FUE.

Platelet-Rich Plasma (PRP) Therapy

• Category: Regenerative / injectable
• Technique: Autologous blood drawn, centrifuged to concentrate platelets and growth factors, then injected into the scalp. Systems referenced include Angel, Cascade, Selphyl, and C-Punt.
• Treatment Time: 3 sessions spaced 30 days apart
• Best Suited For: Patients with early-to-moderate AGA; those seeking a non-surgical option; a clinically appropriate adjunct to FUE
• Recovery: Mild, temporary side effects only; no major complications reported in reviewed studies
• Results Duration: Ongoing maintenance sessions typically required; duration between courses 
• Key Notes: A systematic review and meta-analysis of 12 clinical trials (123 articles identified) reported that 84% of studies recorded positive therapeutic effects. Mean hair count increase was 33.6 hairs per 0.65 cm²; hair density increase was 45.9 hairs/cm². Patient satisfaction scores ranged from 7.0 to 7.1 out of 10. The evidence base positions PRP as a clinically substantiated alternative or adjunct to Minoxidil and Finasteride.

Adult Stem Cell-Based Therapy (ASCs-BT)

• Category: Regenerative / cell-based
• Technique: Mechanical isolation of Hair Follicle Stem Cells (HFSCs) from scalp biopsies, or Adipose-Derived Mesenchymal Stem Cells (AD-MSCs) from fat tissue; injected as autologous micro-grafts
• Best Suited For: Patients seeking follicle niche regeneration; those who have not responded adequately to pharmacological first-line treatment
• Key Notes: Clinical data reported a 29% ± 5% improvement in hair density compared with saline control, assessed 23 weeks after the second injection. The mechanism targets growth factor release and regeneration of the follicle's biological environment rather than mechanical transplantation.

Adipose-Derived Stem Cell Conditioned Medium Infusion

• Category: Regenerative
• Technique: Infusion of medium conditioned by stem cells derived from adipose (fat) tissue
• Best Suited For: Males and females with AGA-related thinning; appropriate candidacy assessed at consultation
• Key Notes: Published clinical outcomes report a mean increment of 29 ± 4.1 hairs in males and 15.6 ± 4.2 hairs in females. This approach targets the paracrine signalling environment of the follicle.

Pharmacological Treatment — Finasteride (1 mg/day, oral)

• Category: Pharmacological / medical
• Technique: Daily oral administration; mechanism is inhibition of 5-alpha-reductase, reducing dihydrotestosterone (DHT) by approximately 65% in serum and scalp
• Treatment Time: Minimum 6–12 months to evaluate efficacy; ongoing use required to sustain benefit
• Best Suited For: Male AGA patients; commonly used as first-line treatment before or alongside surgical intervention
• Recovery: No downtime
• Results Duration: Benefit persists with continued use; loss of effect expected on cessation
• Key Notes: A randomised controlled trial of 212 male patients demonstrated a net improvement of 17.3 ± 2.5 hairs (8.3% ± 1.4%) in total hair count, and 27.0 ± 2.9 hairs (26% ± 3.1%) in anagen hair count at 48 weeks. The anagen-to-telogen ratio improved by 47% net. Results were significantly superior to placebo (p < 0.0001). Not indicated for female patients of childbearing age.

Pharmacological Treatment — Minoxidil (2% or 5%, topical)

• Category: Pharmacological / topical
• Technique: Daily topical application to the scalp; available at 2% and 5% concentrations
• Treatment Time: Minimum 6–12 months; daily application ongoing
• Best Suited For: Male and female AGA patients; appropriate as first-line treatment and as a surgical adjunct
• Recovery: No downtime
• Results Duration: Sustained with continued use; hair loss typically resumes on cessation
• Key Notes: Standalone topical use produced a mean improvement of 18.8 hairs/cm² from baseline at 24 weeks. When combined with electrodynamic micro-needling, the mean improvement increased to 38.3 hairs/cm² at 24 weeks — a clinically meaningful difference supporting combined protocol use. Significantly superior to placebo (p < 0.0001).

Low-Level Laser Therapy (LLLT)

• Category: Non-invasive
• Technique: Exposure of the scalp to low-level lasers to stimulate follicle activity at the cellular level
• Best Suited For: Male and female AGA patients; used as a standalone or adjunct treatment
• Recovery: None
• Key Notes: Meta-analysis of randomised controlled trials indicates effectiveness in promoting hair growth in both males and females (p < 0.0001). Typically integrated within a broader treatment protocol.

Micro-Needling

• Category: Minimally invasive
• Technique: Fine needles rolled across the scalp to puncture the stratum corneum; induces collagen formation, neovascularisation, and local growth factor release. Frequently combined with topical Minoxidil or PRP.
• Best Suited For: AGA patients, particularly where enhanced topical drug delivery or scalp stimulation is the clinical objective
• Key Notes: Pre-clinical model data showed 90% improvement in scalp coverage 12 weeks post-treatment. Clinical combination with Minoxidil produced a mean hair density improvement of 38.3 hairs/cm² at 24 weeks substantially greater than Minoxidil alone (18.8 hairs/cm²).

The Patient Pathway

• Initial enquiry: Patients initiate contact through pre-consultation information gathering includes medical history review and, where possible, photographic documentation of hair loss pattern and progression.
• Consultation: Vera Clinic conducts a structured assessment involving multi-angle photography, grid-based mapping of the hair loss area, computerised phototrichogram analysis, and dermatoscopic evaluation of follicle density. Hair loss is formally graded against the Hamilton-Norwood scale (males) or Ludwig classification (females). This assessment determines candidacy, the most appropriate treatment or treatment combination, and a realistic outcome projection.
• Pre-treatment preparation: Patients undergo laboratory screening for Hepatitis B/C, HIV, and Syphilis prior to any surgical procedure. Smoking and alcohol cessation is required for two weeks before surgery. Relevant medications are reviewed and, where necessary, paused. Donor area trimming is completed on the day of the procedure.
• Procedure (FUE): The patient is positioned prone or laterally for follicular extraction, then supine for implantation. Anaesthesia is administered via ring nerve block and local Lidocaine infiltration with tumescent solution. Individual follicular units are extracted using the LeadM-FUEPK-7000 motorised device, processed microscopically, and implanted using gem knives. Oral Cefradine (antibiotic) is prescribed; Prednisone or Spironolactone is used for oedema management. Patients are advised to sleep semi-upright in the immediate post-operative period.
• Immediate recovery (days 1–6): Oedema typically resolves within 2–3 days. The sterile cap is removed at day 3; hair washing is possible from day 6. Initial recovery is complete within 6–20 days.
• 1–6 month monitoring: Follicle survival and early regrowth are assessed at scheduled clinical evaluations at 1 and 3 months. Hair pull tests are conducted to monitor the anagen-to-telogen transition. Adjunct therapies — PRP, topical Minoxidil, or micro-needling — may be integrated at this stage.
• Final assessment (12–24 months): Hair density and quality are formally evaluated at 12 and 24 months. This is the clinically appropriate timeline for assessing definitive FUE outcomes.

Suitability

Strong candidates for FUE include adults with stable androgenetic alopecia classified at Hamilton-Norwood grades II–V (males) or Ludwig stage I–III (females), whose hair loss has not responded adequately to pharmacological treatment, and who have sufficient donor hair density at the posterior and lateral scalp. Patients should be in general good health and free from active scalp infection or inflammatory conditions.

Patients who may need to wait or require further assessment include those whose hair loss is still actively progressing, younger patients where the long-term loss pattern is uncertain, and individuals on medications that contraindicate surgery. Prior hair transplant patients with a depleted or compromised donor area require careful evaluation before a revision or secondary session is considered.

Patients for whom surgical transplantation is likely unsuitable include those with Hamilton-Norwood grade I (insufficient loss to warrant surgery) or grade VI and above (insufficient donor supply to adequately address the extent of loss), and individuals with systemic illness, active scalp disease, or unrealistic expectations about achievable density.

Non-surgical candidacy is broader. PRP, LLLT, pharmacological treatment, and micro-needling protocols are assessed on an individual basis and may be appropriate where surgery is premature, contraindicated, or not the patient's preferred route.

Results and Clinical Outcomes

Surgical outcomes for FUE are documented in a retrospective study of 158 male patients. Follicle survival exceeded 90%, with 85% of patients achieving individual survival rates above 95%. Average surviving hair density was 35.2 ± 4.3 roots/cm². Patient satisfaction exceeded 98%; the complication rate was below 6%. Hair stability defined as cessation of hair fall was reported by 93.3% of patients within two months of treatment.

For PRP, a systematic review and meta-analysis of 12 clinical trials found that 84% of studies recorded positive therapeutic effects. Mean hair count increased by 33.6 hairs per 0.65 cm² and hair density by 45.9 hairs/cm². Stem cell-based therapy produced a 29% ± 5% improvement in hair density at 23 weeks post-injection. Adipose-derived conditioned medium infusion produced mean increments of 29 ± 4.1 hairs (males) and 15.6 ± 4.2 hairs (females). Results vary between individuals and depend on factors assessed at personal consultation.

Recovery and Aftercare

Following FUE, oedema is managed with oral Prednisone or Spironolactone and resolves within 2–3 days in most cases. The sterile dressing cap is removed at day 3; gentle hair washing begins at day 6. Patients are prescribed oral Cefradine (antibiotic) and are advised to sleep in a semi-upright position to reduce swelling at the recipient area.

Activity restrictions during the initial 6–20 day recovery period should be discussed and confirmed at consultation. Scheduled clinical follow-up is conducted at 1, 3, 6, 12, and 24 months. Remote follow-up options are 

For pharmacological treatments, no physical recovery is required. Both Minoxidil and Finasteride require a minimum of 6–12 months bef

Safety, Risks, and Side Effects

• Common and expected side effects following FUE include temporary oedema at the recipient and donor areas, pinpoint scarring at extraction sites, mild itching during healing, scalp desquamation (flaking), and transient erythema. These are expected features of the healing process and typically resolve within the early recovery period.
• Less common risks include folliculitis (inflammation around grafts), buried graft formation requiring needle extraction, and mild headache. The overall complication rate in the retrospective cohort was below 6%. PRP has a documented profile of mild, transient side effects only; no major complications were reported across the reviewed clinical trials.
• Contraindications and safety protocols: All surgical candidates undergo pre-operative laboratory screening for Hepatitis B/C, HIV, and Syphilis. Smoking and alcohol cessation for two weeks prior to surgery is required. Finasteride is not indicated for female patients of childbearing potential given its teratogenic risk profile. All clinical study protocols at Vera Clinic operate under the oversight of an approved ethics committee. Individual suitability and contraindications are determined at consultation by a qualified practitioner.

Pricing and Consultation Fees

Vera Clinic is based in Istanbul, Turkey, and offers all-inclusive hair transplant packages starting from €3,200. Consultations are provided free of charge, conducted remotely via online assessment or in person at either of its two Istanbul locations.

All-Inclusive Package Pricing 

Price per Graft by Technique

Why Patients Choose Vera Clinic

Vera Clinic's primary clinical differentiator is a published, peer-reviewed evidence base for its core surgical offering. The retrospective FUE cohort study 158 patients, with documented follicle survival and density data is verifiable and cited, rather than promotional. The use of a hospital-based Medical Cosmetology Department, ethics committee oversight, and adherence to international blood-component safety standards positions the clinic within a regulatory framework that not all aesthetic providers operate under.

The breadth of the treatment range spanning surgical, regenerative, pharmacological, and non-invasive options means that patients are assessed against a clinical spectrum rather than directed toward a single commercial offering. Patient-reported outcomes from over 1,800 verified reviews (TrustScore 4.8/5; 95% five-star rated) align consistently with the clinical satisfaction data from retrospective studies.

Reaching the Clinic

Vera Clinic operates across two clinical locations in Istanbul, Turkey, with a main administrative office in the Şişli district.

Clinic Locations

• Kartal Polyclinic: Kordonboyu, Turgut Özal Blv. No: 47, 34860 Kartal / İstanbul
• Ataşehir Medical Center: Küçükbakkalköy, Atilla İlhan Cd. No: 29–31, 34750 Ataşehir / İstanbul
• Main Office: Şişli, Esentepe, Eski Büyükdere Cd. No: 195, Kat 1

By Air

Istanbul is served by Istanbul Airport (IST) and Sabiha Gökçen Airport (SAW). VIP airport transfers are included as standard in all Vera Clinic packages patients are collected on arrival and transferred directly to the clinic partner hotel. No independent transport arrangement is required. 

Search Cheap Flights to Istanbul

By Road

Both clinic locations are accessible by taxi, metro, and private transfer from central Istanbul. The Kartal and Ataşehir sites are on the Asian side of the city. 

Search Car Rental in Istanbul

Accommodation 

Vera Clinic's packages include 3–5 nights at a 4- or 5-star Istanbul hotel, coordinated by the clinic and selected for proximity to the treatment sites. Hotel accommodation, daily transfers between hotel and clinic, and breakfast are included in the package price. 

Search Hotels near Istanbul 

Facilities and Clinical Environment

The clinic operates within a hospital-based Medical Cosmetology Department. The surgical environment follows conventional skin preparation and sterilisation protocols, with compression management of the donor area during and after FUE procedures.

Diagnostic tools used in the consultation and monitoring pathway include a dermatoscope, computerised phototrichogram, and plastic counting grids for follicle density mapping. Surgical extraction is performed using the LeadM-FUEPK-7000 motorised FUE device with 0.8–1 mm sharp punches; implantation uses 1.0–1.2 mm gem knives. PRP preparation is conducted using validated centrifugation systems including Angel, Cascade, Selphyl, and C-Punt.

Post-procedure patient comfort measures include semi-upright sleeping guidance and prescribed pharmaceutical support for oedema management.

Patient Feedback

Patient feedback from over 1,800 verified reviews (Trustpilot TrustScore 4.8/5; 95% five-star rating) identifies several consistent themes.

Positive themes reported across reviews: Staff professionalism and attentiveness; well-organised logistics including airport transfers and clinic transport; clean and modern clinical environment; responsive 24/7 communication from dedicated medical advisors before and after the procedure; and meaningful improvements in hair texture, density, and natural appearance during and after recovery.

Limitations and negative themes reported: Occasional difficulty locating airport pick-up transport at specific departure points; some dissatisfaction regarding schedule flexibility in unforeseen circumstances; complexity and emotional difficulty in revision cases where prior treatment at other clinics had weakened the donor area; a desire for clearer upfront information about post-operative product costs; and temporary discomfort during injection procedures.

Frequently Asked Questions

Is a hair transplant at Vera Clinic suitable for a first-time patient?

FUE is appropriate for first-time patients who have not responded to pharmacological treatment and who meet the candidacy criteria for their degree of hair loss. Patients at Hamilton-Norwood grade I, or those with actively progressing loss, are generally not advised to proceed with surgery at the initial presentation; a consultation will determine whether timing is appropriate.

Is the FUE procedure painful?

The procedure is performed under local anaesthesia — ring nerve block and Lidocaine infiltration — and most patients describe the experience as producing tolerable, manageable discomfort rather than significant pain. Injection-related discomfort is the most commonly reported form of temporary pain during the procedure.

What is the recovery period after FUE?

Oedema typically resolves within 2–3 days; the sterile cap is removed at day 3 and gentle washing begins at day 6. Most patients consider initial recovery complete within 6–20 days. Clinical evaluations are scheduled at 1, 3, 6, 12, and 24 months, with final density assessment at 12–24 months.

How long do FUE results last?

Transplanted follicles are taken from genetically stable, non-balding donor areas and are designed to produce permanent terminal hair growth. The 12–24 month assessment is the clinically appropriate point at which permanent outcomes can be evaluated.

How many sessions does hair transplant or PRP require?

FUE typically requires a single session; a secondary session may be considered for additional density where the donor supply permits. PRP is delivered across three sessions spaced 30 days apart. Pharmacological treatments require daily ongoing use for a minimum of 6–12 months before efficacy can be assessed.

Who is not a suitable candidate for hair transplant?

Hair transplant surgery is not indicated for patients with Hamilton-Norwood grade I (insufficient loss to clinically justify surgery) or grades VI and above (insufficient donor supply), those with active scalp or systemic disease, individuals on medications contraindicated for surgery, and patients whose expectations cannot be met by the available donor supply. A consultation determines suitability for each individual.

How do I arrange a consultation?

Consultations are free of charge and available online. Patients can submit an enquiry via the Vera Clinic website or contact the team directly on WhatsApp. A patient coordinator will follow up to gather information, assess your case remotely, and confirm your individual treatment plan and package cost before any commitment is made.

Arrange a Consultation

Hair restoration is a considered clinical decision. The appropriateness of any particular procedure and the realistic outcome for your specific pattern of hair loss can only be determined by a qualified practitioner at a personal assessment. The consultation at Vera Clinic is free of charge, available online, and covers a formal grading of your hair loss, photographic and phototrichogram-based follicle mapping, and a full review of your medical history before any treatment pathway is discussed.

↑ Back to Top

Disclaimer

This page contains general clinical information only and does not constitute medical advice. If you have a health condition or are taking medication, consult a qualified medical professional before pursuing any treatment. Suitability for any procedure described on this page is determined by a qualified practitioner at a personal assessment, and no content here should be taken as a recommendation for your individual case. Results vary between individuals and depend on factors including degree of hair loss, donor supply, age, and overall health, all of which are assessed at consultation. All prices shown are indicative, depend on your individual case, and are confirmed at consultation no pricing is guaranteed in advance. This page may contain affiliate or partner links including travel and accommodation search tools for which this site may earn a referral fee at no additional cost to you; this does not influence any clinical information presented or the price you pay for treatment.